REFERENCES
1 – Civil Protection Department of the Italian Government:http://opendatadpc.maps.arcgis.com/apps/opsdashboard/index.html#/b0c68bce2cce478eaac82fe38d4138b1(Accessed the 18th June 2020)
2 - McMichael TM, Currie DW, Clark S, Pogosjans S, Kay M, Schwartz NG,
Lewis J, Baer A, Kawakami V, Lukoff MD, Ferro J, Brostrom-Smith C, Rea
TD, Sayre MR, Riedo FX, Russell D, Hiatt B, Montgomery P, Rao AK, Chow
EJ, Tobolowsky F, Hughes MJ, Bardossy AC, Oakley LP, Jacobs JR, Stone
ND, Reddy SC, Jernigan JA, Honein MA, Clark TA, Duchin JS. Epidemiology
of Covid-19 in a Long-Term Care Facility in King County, Washington. N
Engl J Med. 2020 Mar 27. doi: 10.1056/NEJMoa2005412
3 - Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and
Characteristics of Patients Dying in Relation to COVID-19 in Italy.
JAMA. 2020. doi: 10.1001/jama.2020.4683.
4 - Pennington E. Asthma increases risk of severity of COVID-19. Cleve
Clin J Med. 2020. doi: 10.3949/ccjm.87a.ccc002.
5 - Busse WW, Lemanske RF Jr, Gern JE. Role of viral respiratory
infections in asthma and asthma exacerbations. Lancet. 2010 Sep
4;376(9743):826-34
6 - Contoli M, Ito K, Padovani A, Poletti D, Marku B, Edwards MR,
Stanciu LA, Gnesini G, Pastore A, Spanevello A, Morelli P, Johnston SL,
Caramori G, Papi A. Th2 cytokines impair innate immune responses to
rhinovirus in respiratory epithelial cells. Allergy. 2015;70(8):910-20.
doi: 10.1111/all.12627.
7 - Sajuthi SP, DeFord P, Jackson ND, Montgomery MT, Everman JL, Rios
CL, Pruesse E, Nolin JD, Plender EG, Wechsler ME, Mak ACY, Eng C,
Salazar S, Medina V, Wohlford EM, Huntsman S, Nickerson DA, Germer S,
Zody MC, Abecasis G, Kang HM, Rice KM, Kumar R, Oh S, Rodriguez-Santana
J, Burchard EG, Seibold MA. Type 2 and interferon inflammation strongly
regulate SARS-CoV-2 related gene expression in the airway epithelium.
bioRxiv 2020.04.09.034454
8 - Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, Shi J, Zhou M, Wu B, Yang
Z, Zhang C, Yue J, Zhang Z, Renz H, Liu X, Xie J, Xie M, Zhao J. Risk
factors for severity and mortality in adult COVID-19 inpatients in
Wuhan. J Allergy Clin Immunol. 2020 Apr 12. pii: S0091-6749(20)30495-4.
doi: 10.1016/j.jaci.2020.04.006.
9 - Siordia JA Jr. Epidemiology and clinical features of COVID-19: A
review of current literature. J Clin Virol. 2020 Apr 10;127:104357. doi:
10.1016/j.jcv.2020.104357.
10 - Zhang JJ, Cao YY, Dong X, Wang BC, Liao MY, Lin J, Yan YQ, Akdis
CA, Gao YD. Distinct characteristics of COVID-19 patients with initial
rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2. Allergy.
2020. doi: 10.1111/all.14316
11 - Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock
IM, Bateman ED, Bel EH, Bleecker ER, Boulet LP, Brightling C, Chanez P,
Dahlen SE, Djukanovic R, Frey U, Gaga M, Gibson P, Hamid Q, Jajour NN,
Mauad T, Sorkness RL, Teague WG. International ERS/ATS guidelines on
definition, evaluation and treatment of severe asthma. Eur Respir J.
2014 Feb;43(2):343-73.
12 - Senna G, Guerriero M, Paggiaro PL, Blasi F, Caminati M, Heffler E,
Latorre M, Canonica GW; SANI. SANI-Severe Asthma Network in Italy: a way
forward to monitor severe asthma. Clin Mol Allergy. 2017;15:9.
13 - Heffler E, Blasi F, Latorre M, Menzella F, Paggiaro P, Pelaia G,
Senna G, Canonica GW; SANI Network. The Severe Asthma Network in Italy:
Findings and Perspectives. J Allergy Clin Immunol Pract.
2019;7(5):1462-1468.
14 - Kaye L, Theye B, Smeenk I, Gondalia R, Barrett MA, Stempel DA.
Changes in medication adherence among patients with asthma and COPD
during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2020. doi:
10.1016/j.jaip.2020.04.053.
15 - Jackson DJ, Busse WW, Bacharier LB, Kattan M, O’Connor GT, Wood RA,
Visness CM, Durham SR, Larson D, Esnault S, Ober C, Gergen PJ, Becker P,
Togias A, Gern JE, Altman MC. Association of respiratory allergy,
asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin
Immunol. 2020. doi: 10.1016/j.jaci.2020.04.009.
16 - Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link
between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med 2020.
doi: 10.1016/j.ejim.2020.04.037.
17 - Papi A, Papadopoulos NG, Degitz K, Holgate ST, Johnston SL.
Corticosteroids inhibit rhinovirus-induced intercellular adhesion
molecule-1 up-regulation and promoter activation on respiratory
epithelial cells. J Allergy Clin Immunol 2000;105:318-26.
18 - Ciprandi G, Buscaglia S, Pesce G, Pronzato C, Ricca V, Parmiani S,
Bagnasco M, Canonica GW. Minimal persistent inflammation is present at
mucosal level in patients with asymptomatic rhinitis and mite allergy. J
Allergy Clin Immunol. 1995;96(6 Pt 1):971-9.
19 - Peters MC, Sajuthi S, Deford P, Christenson S, Rios CL, Montgomery
MT, Woodruff PG, Mauger DT, Erzurum SC, Johansson MW, Denlinger LC,
Jarjour NN, Castro M, Hastie AT, Moore W, Ortega VE, Bleecker ER, Wenzel
SE, Israel E, Levy BD, Seibold MA, Fahy JV; National Heart, Lung, and
Blood Institute Severe Asthma Research Program-3 Investigators. COVID-19
Related Genes in Sputum Cells in Asthma: Relationship to Demographic
Features and Corticosteroids. Am J Respir Crit Care Med. 2020. doi:
10.1164/rccm.202003-0821OC.
20 - Yamaya M, Nishimura H, Deng X, Sugawara M, Watanabe O, Nomura K,
Shimotai Y, Momma H, Ichinose M, Kawase T. Inhibitory effects of
glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E
replication and cytokine production by primary cultures of human nasal
and tracheal epithelial cells. Respir Investig. 2020;58(3):155-168. doi:
10.1016/j.resinv.2019.12.005.
21 - Gill MA, Liu AH, Calatroni A, Krouse RZ, Shao B, Schiltz A, Gern
JE, Togias A, Busse WW. Enhanced plasmacytoid dendritic cell antiviral
responses after omalizumab. J Allergy Clin Immunol.
2018;141(5):1735-1743.e9. doi: 10.1016/j.jaci.2017.07.035.
22 - Contoli M, Papi A. Effects of Anti-IL-5 on Virus-induced
Exacerbation in Asthma. Light and Shadow. Am J Respir Crit Care Med.
2019;199(4):410-411. doi: 10.1164/rccm.201809-1684ED.
23 - Jesenak M, Banovcin P, Diamant Z. COVID‐19, chronic inflammatory
respiratory diseases and eosinophils – Observationsfrom reported
clinical case series. Allergy 2020. doi:10.1111/all.14353
24 - Liu F, Xu A, Zhang Y, Xuan W, Yan T, Pan K, Yu W, Zhang J. Patients
of COVID-19 may benefit from sustained Lopinavir-combined regimen and
the increase of Eosinophil may predict the outcome of COVID-19
progression. Int J Infect Dis. 2020;95:183-191. doi:
10.1016/j.ijid.2020.03.013.